Abstract

Functional studies can be utilized to give importance/relevance to clinical associations. Once a clinical genetic or pharmacogenetic association is found, molecular studies can be utilized to explore the mechanism for the association. By employing cells in culture or transgenic mice modified with specific variant genes or sequence polymorphisms of interest, pathophysiological processes and response to pharmacological agents may be tested under conditions that are not approachable in human patients. These mechanistic studies may be particularly important when it comes to pharmacogenetic associations by providing significant, clinically relevant insights into the variable responses patients show to drug therapy.

Original languageEnglish
Title of host publicationPharmacogenomics in Drug Discovery and Development
Subtitle of host publicationFrom Bench to Bedside
PublisherHumana Press
Pages379-393
Number of pages15
ISBN (Print)9781588298874
DOIs
StatePublished - Jan 1 2008

Publication series

NameMethods in Molecular Biology
Volume448
ISSN (Print)1064-3745

Keywords

  • Candidate gene
  • Cardiovascular
  • Functional genomics
  • Pharmacogenomics
  • Single-nucleotide polymorphism (SNP).

Fingerprint

Dive into the research topics of 'From SNPs to functional studies in cardiovascular pharmacogenomics'. Together they form a unique fingerprint.

Cite this